STAT+: Pharmalittle: We’re reading about weight loss drug spending, launch prices for medicines, and much more

Americans are increasing their healthcare utilization, including doctor visits, hospital procedures, and prescription fillings, at a rate exceeding earlier economic projections, according to STAT. This trend is significantly influenced by the burgeoning spending on weight loss drugs, which are straining national healthcare budgets. In 2025, the United States spent $5.7 trillion on healthcare, representing a 7.3% increase from 2024, or nearly $16,500 per capita, as reported in Health Affairs. Prescription drug spending alone saw a substantial rise of over 11% in 2025. In parallel, advancements are being made in treating aggressive breast cancer. Gilead Sciences secured FDA approval for its drug Trodelvy as an initial treatment for newly diagnosed patients with advanced triple-negative breast cancer, a form that typically resists standard therapies. This follows the May approval of AstraZeneca and Daiichi Sankyo's Datroway for a comparable patient group, marking a period of significant progress after decades of limited breakthroughs in this area.